指南与共识泌尿生殖介入MRUS

前列腺磁共振成像/超声融合引导活检对放射治疗推荐的影响

Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.
指南 / 共识 · Int J Radiat Oncol Biol Phys · 2016-12-18

研究纳入2008年1月至2016年1月在本机构接受放疗并同时行标准超声引导活检(SOC-Bx)和MRI/超声融合活检(MRI-Bx)的73例患者,比较活检方式对NCCN风险分组及放疗/雄激素剥夺治疗(ADT)推荐的影响。结果显示MRI-Bx较既往SOC-Bx更常见Gleason评分升高,并将极高危患者比例从24.7%提高至41.1%(P=.027),纳入MRI-Bx结果后73例中28例ADT疗程增加、8例新增ADT。作者指出依据MRI-Bx发现强化治疗的获益尚不明确。

要点

  • MRI-Bx较既往SOC-Bx更常见Gleason评分升高:评分7为6.7% vs 44.6%(P<.001),评分8-10为2.1% vs 38%(P<.001)。
  • MRI-Bx使极高危患者比例从24.7%升至41.1%(P=.027)。
  • 纳入MRI-Bx结果后73例中28例ADT疗程增加、8例新增ADT,但强化治疗的获益尚不明确。

核心结论

  • 在接受放疗的患者中,MRI-Bx使阳性针芯百分比、Gleason评分和风险分组升高;依据MRI-Bx发现强化治疗的获益尚不明确。

研究设计与样本

  • 单中心研究,纳入2008年1月至2016年1月在本机构接受放疗并同时行SOC-Bx和MRI-Bx的73例患者(其中47例既往有SOC-Bx),依据临床T分期、治疗前前列腺特异性抗原和Gleason评分进行NCCN风险分组并给出放疗或ADT推荐。

诊断标准与关键数值

  • 与既往SOC-Bx相比,重复SOC-Bx和MRI-Bx后Gleason评分7的比例为6.7% vs 44.6%(P<.001),Gleason评分8-10的比例为2.1% vs 38%(P<.001)。
  • MRI-Bx使极高危患者比例从24.7%升至41.1%(P=.027)。
  • 与单独SOC-Bx相比,纳入MRI-Bx发现后病理阳性针芯百分比均值从37%升至44%。

临床应用与阅片要点

  • 纳入MRI-Bx结果后,73例中28例ADT疗程增加、8例新增ADT,提示活检方式可影响放疗和ADT推荐。
  • 作者指出依据MRI-Bx发现强化治疗的获益尚不明确。

局限性

  • 依据MRI-Bx发现强化治疗的获益尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Targeted magnetic resonance imaging (MRI)/ultrasound fusion prostate biopsy (MRI-Bx) has recently been compared with the standard of care extended sextant ultrasound-guided prostate biopsy (SOC-Bx), with the former associated with an increased rate of detection of clinically significant prostate cancer. The present study sought to determine the influence of MRI-Bx on radiation therapy and androgen deprivation therapy (ADT) recommendations.

METHODS AND MATERIALS: All patients who had received radiation treatment and had undergone SOC-Bx and MRI-Bx at our institution were included. Using the clinical T stage, pretreatment prostate-specific antigen, and Gleason score, patients were categorized into National Comprehensive Cancer Network risk groups and radiation treatment or ADT recommendations assigned. Intensification of the recommended treatment after multiparametric MRI, SOC-Bx, and MRI-Bx was evaluated.

RESULTS: From January 2008 to January 2016, 73 patients received radiation therapy at our institution after undergoing a simultaneous SOC-Bx and MRI-Bx (n=47 with previous SOC-Bx). Repeat SOC-Bx and MRI-Bx resulted in frequent upgrading compared with previous SOC-Bx (Gleason score 7, 6.7% vs 44.6%; P<.001; Gleason score 8-10, 2.1% vs 38%; P<.001). MRI-Bx increased the proportion of patients classified as very high risk from 24.7% to 41.1% (P=.027). Compared with SOC-Bx alone, including the MRI-Bx findings resulted in a greater percentage of pathologically positive cores (mean 37% vs 44%). Incorporation of multiparametric MRI and MRI-Bx results increased the recommended use and duration of ADT (duration increased in 28 of 73 patients and ADT was added for 8 of 73 patients).

CONCLUSIONS: In patients referred for radiation treatment, MRI-Bx resulted in an increase in the percentage of positive cores, Gleason score, and risk grouping. The benefit of treatment intensification in accordance with the MRI-Bx findings is unknown.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Reed A, Valle LF, Shankavaram U, et al. Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations. Int J Radiat Oncol Biol Phys. 2016. PMID: 28333017. doi:10.1016/j.ijrobp.2016.12.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。